Half-year report · HY

Period2025-04-01 → 2025-09-30
Filed2025-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥12.4bn2025-04-01 → 2025-09-30Cons.Net sales
Revenue¥22.5bn2024-04-01 → 2025-03-31Cons.Net sales (5-year summary)
Revenue¥11.4bn2024-04-01 → 2024-09-30Cons.Net sales
Operating income¥1.6bn2025-04-01 → 2025-09-30Cons.Operating income
Operating income¥1.9bn2024-04-01 → 2024-09-30Cons.Operating income
Ordinary income¥1.7bn2025-04-01 → 2025-09-30Cons.Ordinary income
Ordinary income¥3.5bn2024-04-01 → 2025-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.9bn2024-04-01 → 2024-09-30Cons.Ordinary income
Profit before tax¥1.7bn2025-04-01 → 2025-09-30Cons.Income before income taxes
Profit before tax¥2.1bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Net income (owners)¥1.1bn2025-04-01 → 2025-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.2bn2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.3bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income¥1.2bn2025-04-01 → 2025-09-30Cons.Profit loss
Net income¥1.5bn2024-04-01 → 2024-09-30Cons.Profit loss
Total assets¥34.9bnat 2025-09-30Cons.Assets
Total assets¥35.4bnat 2025-03-31Cons.Assets
Total assets¥32.6bnat 2024-09-30Cons.Total assets (5-year summary)
Total liabilities¥10.2bnat 2025-09-30Cons.Liabilities
Total liabilities¥9.8bnat 2025-03-31Cons.Liabilities
Net assets / equity¥24.7bnat 2025-09-30Cons.Net assets
Net assets / equity¥25.5bnat 2025-03-31Cons.Net assets
Net assets / equity¥24.4bnat 2024-09-30Cons.Net assets (5-year summary)
Cash and deposits¥13.7bnat 2025-09-30Cons.Cash and deposits
Cash and deposits¥15.4bnat 2025-03-31Cons.Cash and deposits
Cash & equivalents¥13.7bnat 2025-09-30Cons.Cash and cash equivalents
Cash & equivalents¥15.4bnat 2025-03-31Cons.Cash and cash equivalents
Cash & equivalents¥15.7bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥14.0bnat 2024-03-31vCons.Cash and cash equivalents
Operating cash flow¥1.4bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥2.7bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.2bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥998m2025-04-01 → 2025-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.9bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥1.1bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥1.9bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in financing activities
Financing cash flow¥553m2024-04-01 → 2025-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥703m2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥145.462025-04-01 → 2025-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥292.412024-04-01 → 2025-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥170.42024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio66.4%at 2025-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio67.8%at 2025-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio70.3%at 2024-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
Medical Relatedreportable segmentrevenue2025-04-01 → 2025-09-30¥1.5bn
Medical Relatedreportable segmentrevenue external2025-04-01 → 2025-09-30¥1.5bn
Medical Relatedreportable segmentsegment profit2025-04-01 → 2025-09-30¥108m
Water Health Carereportable segmentrevenue2025-04-01 → 2025-09-30¥10.9bn
Water Health Carereportable segmentrevenue external2025-04-01 → 2025-09-30¥10.9bn
Water Health Carereportable segmentsegment profit2025-04-01 → 2025-09-30¥1.5bn
—segment totalrevenue2025-04-01 → 2025-09-30¥12.4bn
—segment totalrevenue external2025-04-01 → 2025-09-30¥12.4bn
—segment totalsegment profit2025-04-01 → 2025-09-30¥1.6bn
Medical Relatedreportable segmentrevenue2024-04-01 → 2024-09-30¥1.4bn
Medical Relatedreportable segmentrevenue external2024-04-01 → 2024-09-30¥1.4bn
Medical Relatedreportable segmentsegment profit2024-04-01 → 2024-09-30¥215m
Water Health Carereportable segmentrevenue2024-04-01 → 2024-09-30¥9.9bn
Water Health Carereportable segmentrevenue external2024-04-01 → 2024-09-30¥9.9bn
Water Health Carereportable segmentsegment profit2024-04-01 → 2024-09-30¥1.6bn
—segment totalrevenue2024-04-01 → 2024-09-30¥11.4bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥11.4bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥1.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 518
ItemContextValueUnit
Net defined benefit liabilityPrior1YearInstant367842000JPY
Net defined benefit liabilityInterimInstant384596000JPY
Other nclPrior1YearInstant715786000JPY
Other nclInterimInstant790962000JPY
Noncurrent liabilitiesPrior1YearInstant2652578000JPY
Noncurrent liabilitiesInterimInstant2748891000JPY
LiabilitiesPrior1YearInstant9807610000JPY
LiabilitiesInterimInstant10205523000JPY
Capital stockPrior1YearInstant992597000JPY
Capital stockInterimInstant992597000JPY
Capital surplusPrior1YearInstant1864182000JPY
Capital surplusInterimInstant1807969000JPY
Retained earningsPrior1YearInstant24391935000JPY
Retained earningsInterimInstant24421538000JPY
Treasury stockPrior1YearInstant-3408285000JPY
Treasury stockInterimInstant-4066723000JPY
Shareholders equityPrior1YearInstant23840429000JPY
Shareholders equityInterimInstant23155381000JPY
Valuation difference on available for sale securitiesPrior1YearInstant-14881000JPY
Valuation difference on available for sale securitiesInterimInstant-11639000JPY
Foreign currency translation adjustmentPrior1YearInstant108612000JPY
Foreign currency translation adjustmentInterimInstant27243000JPY
Remeasurements of defined benefit plansPrior1YearInstant33004000JPY
Remeasurements of defined benefit plansInterimInstant26689000JPY
Valuation and translation adjustmentsPrior1YearInstant126735000JPY
Valuation and translation adjustmentsInterimInstant42293000JPY
Non controlling interestsPrior1YearInstant1579004000JPY
Non controlling interestsInterimInstant1523031000JPY
Net assetsPrior1YearInstant25546169000JPY
Net assetsInterimInstant24720706000JPY
Liabilities and net assetsPrior1YearInstant35353779000JPY
Liabilities and net assetsInterimInstant34926229000JPY
Net salesPrior1InterimDuration11361310000JPY
Net salesInterimDuration12406169000JPY
Cost of salesPrior1InterimDuration3383217000JPY
Cost of salesInterimDuration3922080000JPY
Gross profitPrior1InterimDuration7978092000JPY
Gross profitInterimDuration8484089000JPY
Selling general and administrative expensesPrior1InterimDuration6121576000JPY
Selling general and administrative expensesInterimDuration6920886000JPY
Operating incomePrior1InterimDuration1856516000JPY
Operating incomeInterimDuration1563202000JPY
Interest and dividends income noiPrior1InterimDuration25932000JPY
Interest and dividends income noiInterimDuration51770000JPY
Equity in earnings of affiliates noiPrior1InterimDuration12303000JPY
Equity in earnings of affiliates noiInterimDuration8925000JPY
Real estate rent noiPrior1InterimDuration42008000JPY
Real estate rent noiInterimDuration42008000JPY
Foreign exchange gains noiPrior1InterimDuration-JPY
Foreign exchange gains noiInterimDuration623000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-03-31pass
balance sheet identityconsolidated 2025-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-03-31pass
statement vs summary · net assetsconsolidated 2025-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2025-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2025-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2025-04-01/2025-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2025-09-30pass